id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-V-0192-0010,FDA,FDA-2021-V-0192,Variance Approval Letter from FDA CDRH to Digital Projection Inc.,Other,Approval for Variance (VRA),2024-02-06T05:00:00Z,2024,2,2024-02-06T05:00:00Z,,2024-02-06T16:23:39Z,,0,0,09000064863e85e6
FDA-2021-V-0192-0009,FDA,FDA-2021-V-0192,Variance Amendment Report from Digital Projection Inc,Other,Amendment,2024-01-30T05:00:00Z,2024,1,2024-01-30T05:00:00Z,,2024-01-30T17:23:54Z,,0,0,09000064863d0951
FDA-2021-V-0192-0008,FDA,FDA-2021-V-0192,Amended Variance Approval Letter from FDA CDRH to Digital Projection Inc.,Other,Approval for Variance (VRA),2024-01-25T05:00:00Z,2024,1,2024-01-25T05:00:00Z,,2024-01-25T17:19:56Z,,0,0,09000064863c2f7b